Esomeprazole (Nexium)
UK Medicines Information, 2001
· European patent protection for omeprazole expires in 2002 when cheaper, generic versions are likely
· Evaluation of esomeprazole studies is complicated both by the fact that, currently, many are published
esomeprazole will necessitate determining the patients for whom such use of a PPI is appropriate, i.e.
· At a dose of 40mg daily, esomeprazole has been found to be statistically significantly more effective
View rest of article at www.ukmi.nhs.uk «
Related articles
Below are some of our articles related to the article above:
The TRIP Database is a clinical search tool designed to allow health professionals to rapidly identify the highest quality clinical evidence for clinical practice.
Registered users (registration is free) benefit from extra features such as CPD, search history, and collaborative tools. Register here, or Login if you have registered before.
Find out more about Trip Database.
